Our next shoAIcase episode takes a deep dive into how AI meets healthcare innovation!
We’re thrilled to host Dr. Geetha Manjunath, the visionary founder of NIRAMAI Health Analytix, to talk about Thermalytix – An AI-Powered, Non-Invasive, Radiation-Free, and Portable System for Early-Stage Breast Cancer Detection
Brief Overview:
Thermalytix is an AI-powered, non-invasive, radiation-free, and portable breast health screening solution developed by NIRAMAI Health Analytix. It leverages advanced thermal imaging and machine learning to detect early signs of breast cancer, offering a painless and privacy-respecting screening experience. The solution is especially impactful for women of all age groups and underserved communities, enabling accessible and affordable early detection.
About the Speaker:
Dr. Geetha Manjunath is the Founder, CEO, and CTO of NIRAMAI Health Analytix, and has pioneered a breakthrough AI-based test for early-stage breast cancer detection using thermal imaging. A Computer Scientist with a Ph.D. from the Indian Institute of Science and management education from Kellogg’s Chicago, Dr. Geetha brings over 25 years of experience in IT innovation, having led AI and data analytics research at Xerox Research and Hewlett Packard Labs before founding NIRAMAI.
She has received numerous national and international accolades, including the CSI Gold Medal, BIRAC WinER Award 2018, and recognition in the Forbes List of Top 20 Self-Made Women (2020). She has also been honored as Accenture Vahini Innovator of the Year by The Economic Times and Women Entrepreneur of the Year 2020 by BioSpectrum India.
Dr. Geetha is the co-author of the book “Moving to the Cloud” and holds 50+ US patents. Her expertise spans Artificial Intelligence, Machine Learning, Computer Vision, Data Analytics, Cloud Computing, and HealthTech Innovation.